EBIM
LH icon

Eagle Boston Investment Management’s Labcorp LH Stock Holding History

Eagle Boston Investment Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,280
Closed -$351K – 134
2018
Q2 		$351K Sell
2,280
-3
-0.1% -$453 0.03% 124
2018
Q1 		$317K Buy
2,283
+62
+3% +$9.11K 0.03% 129
2017
Q4 		$321K Buy
+2,221
New +$294K 0.03% 125

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Eagle Boston Investment Management's LH Position: Q3 2018 in Review

Eagle Boston Investment Management sold out of Labcorp (LH) in Q3 2018, closing a stake of 2,280 shares — an estimated $351K sold.

Eagle Boston Investment Management first reported a position in LH in Q4 2017 and held it in 3 quarters. The position peaked at $351K in Q2 2018. 794 funds tracked by Wall St. Rank hold LH as of Q3 2018.

  • Eagle Boston Investment Management reported no remaining Labcorp position as of Q3 2018 after selling out during the quarter.
  • Eagle Boston Investment Management sold 2,280 Labcorp shares in Q3 2018, an estimated $351K.
  • Eagle Boston Investment Management first reported a position in Labcorp in Q4 2017 and held it in 3 quarters.
  • Eagle Boston Investment Management's Labcorp position peaked at $351K in Q2 2018.
  • 794 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Eagle Boston Investment Management's 13F filing for Q3 2018, filed 8 Nov 2018.